NCT03297112View on ClinicalTrials.gov

Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

September 4, 2018

Study Completion Date

September 4, 2018

Conditions
Adnexal Mass
Interventions
DRUG

Perflutren Lipid Microspheres

Given IV

PROCEDURE

Contrast-Enhanced Subharmonic Ultrasound Imaging

Undergo contrast-enhanced subharmonic ultrasound imaging

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Lantheus Medical Imaging
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Lantheus Medical Imaging

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER